You are here:
25 April 2019 / deal

Loyens & Loeff advised Eurazeo Capital on the acquisition of DORC Group from Montagu

Loyens & Loeff advised Eurazeo Capital, a France-based, leading global investment company listed on Euronext Paris, on the acquisition of DORC (Dutch Ophthalmic Research Center) a Netherlands-based company which operates in the medical technology sector and designs, manufactures and distributes ophthalmic surgery equipment, from Montagu Private Equity, a European private equity firm with headquarters in London.

Eurazeo Capital will invest close to 300M€ in this transaction. DORC will be the fifth investment of Eurazeo Capital IV. This investment perfectly fits the strategy presented during the 2018 Annual Results presentation.

Building windows three colors


EUTA Special Edition: EU responses to COVID-19 crisis

Update 5 June 2020 - The COVID-19 (Coronavirus) pandemic is affecting hundreds of thousands of people and is leading, all over the world, to far-reaching health... read more

Loyens & Loeff has advised Mitsubishi Corporation and NTT

Loyens & Loeff has advised MC and Nippon Telegraph and Telephone Corporation NTT on the joint acquisition of a 30% stake in HERE Technologies. read more

Easy reference overview MSLA Act

This document contains an overview of the changes to Book 2 of the Dutch Civil Code in connection with the MSLE Act. read more